Intravenous Iron Alone for the Treatment of Anemia in Patients With Chronic Heart Failure
Aidan P. Bolger, BSc, MRCP*,*,
Frederick R. Bartlett, MBBS ,
Helen S. Penston, SRN ,
Justin OLeary, BSc, DMU*,
Noel Pollock, MBBS ,
Raffi Kaprielian, MD, MRCP and
Callum M. Chapman, MRCP
* Department of Clinical Cardiology, The Heart Hospital, London, United Kingdom
Clinical Heart Failure Service, West Middlesex University Hospital, Isleworth, United Kingdom.

View larger version (19K):
[in a new window]
|
Figure 1 Changes in hemoglobin (Hb) for each participant after treatment with iron sucrose. Baseline and completion Hb ± SD for the whole group is denoted by the values between the error bars.
|
|

View larger version (20K):
[in a new window]
|
Figure 2 Relationships between change in hemoglobin and changes in Minnesota Living with Heart Failure (MLHF) score and 6-min walk (6MW) distance.
|
|
|